We are happy to announce that our solid-state ChIP technology has been selected to power a new range of faster and more efficient chromatin immunoprecipitation kits by BioLegend, a major US-based manufacturer and supplier of reagents and kits for biomedical research.

Combining Biolegend’s expertise in developing ChIP-validated Go-ChIP-Grade™ antibodies with the patented Chromatrap® solid-state immunocapture, the new range of ChIP-sequencing kits is expected to be a leader on the market, meeting a critical need which arises from the rapid growth of ChIP-seq, and allows researchers to perform faster, simpler and more sensitive assays for their epigenetics research.

According to Dr Amy Beynon, Product Development Manager for Chromatrap®, "The wide distribution network offered by BioLegend is an ideal way to expand the reach of our proven novel solid-state ChIP technology. Access to important geographical markets where BioLegend is an established and trusted supplier forms the core of our relationship. We look forward to supporting many more researchers as BioLegend expands the usage of Chromatrap technology across these markets."

Together with BioLegend, we are aiming to make the Go-ChIP-Grade™ antibodies and ChIP kits incorporating Chromatrap technology the method of choice for ChIP-sequencing in the future. Our collaboration includes providing BioLegend with access to our revolutionary spin columns and proprietary buffers to use in the new ChIP-sequencing kits worldwide.

BioLegend develops and manufactures highly recognised, world-class antibodies and reagents at outstanding value to customers for biomedical research. Their proactive product development program, accomplished through technology licensing, collaborations, and internal research and development, has produced an extensive product offering, which have been collectively cited in over 25,000 peer-reviewed journals. BioLegend also offers a wide range of custom services including assay development, sample testing, and conjugation.